Iron Absorption From Iron Fortified Extruded Rice Co-fortified With Various Solubilizing Agents

Overview

Food fortification is regarded as a safe and cost-effective approach to counteract and prevent iron deficiency. Rice is a staple food for millions of people living in regions where iron-deficiency anaemia is a significant public health problem. Therefore, rice may be a promising fortification vehicle. Ferric pyrophosphate (FePP) is an acceptable iron compound for rice fortification, due to its white colour and low reactivity with the rice matrix. However, iron from FePP generally has a low bioavailability. To increase the low iron bioavailability of FePP in fortified rice, ligands acting as solubilizing agents have been suggested, such as citric acid/trisodium citrate (CA/TSC), ethylenediaminetetraacetic acid (EDTA) and sodium pyrophosphate (NaPP). It is however unclear to which extent CA/TSC would enhance iron bioavailability in presence of phytic acid, a common inhibitor of iron absorption found in whole grains and legumes. Zinc oxide reduces iron bioavailability from FePP with and without CA/TSC, in contrast to Zinc sulphate. It is however unclear if this decrease would be also expected in presence of EDTA as solubilizing agent. Further, NaPP has been suggested as a solubilizing agent, enhancing the bioavailability from FePP in bouillon cubes. This study aim to test its effect in rice. Meals containing a high (bean sauce) and low (mixed vegetable) phytic acid level sauce will be used to simulated varying dietary backgrounds, allowing to answer the question which solubilizing agent is viable in enhancing iron bioavailability.

Full Title of Study: “Effect of Solubilizing Agents on Iron Absorption From Iron Fortified Rice in Young Women”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Crossover Assignment
    • Primary Purpose: Prevention
    • Masking: Single (Participant)
  • Study Primary Completion Date: December 2018

Interventions

  • Dietary Supplement: Reference meal 1
    • 1 ml Ferrous sulfate solution (4mgFe/ml) was added in cooked comercial Rice Prior to served to participant. The meal served with 30 g mixed vegetable Sauce and 300 ml nanopure water
  • Dietary Supplement: Reference 2
    • 1 ml Ferrous sulphate solution (4mgFe/ml) was added in cooked comercial Rice Prior to served to participant. The meal served with 30 g bean Sauce and 300 ml nanopure water
  • Dietary Supplement: Test meal A
    • Fortified extruded Rice was mixed with Commercial Rice (mixing Ratio: 1:100) The meal served with 30 g vegetable Sauce and 300 ml nanopure water. ** composition of extruded Rice: Ferric pyrophosphate, zinc oxide and ethylenediaminetetraacetic acid
  • Dietary Supplement: Test meal B
    • Fortified extruded Rice was mixed with Commercial Rice (mixing Ratio: 1:100) The meal served with 30 g vegetable Sauce and 300 ml nanopure water. ** composition of extruded Rice: Ferric pyrophosphate, zinc sulfate and ethylenediaminetetraacetic acid
  • Dietary Supplement: Test meal C
    • Fortified extruded Rice was mixed with Commercial Rice (mixing Ratio: 1:100) The meal served with 30 g vegetable Sauce and 300 ml nanopure water. ** composition of extruded Rice: Ferric pyrophosphate, zinc sulfate, citric acid and trisodium Citrate.
  • Dietary Supplement: Test meal D
    • Fortified extruded Rice was mixed with Commercial Rice (mixing Ratio: 1:100) The meal served with 30 g vegetable Sauce and 300 ml nanopure water. ** composition of extruded Rice: Ferric pyrophosphate, zinc sulfate and sodium pyrophosphate.
  • Dietary Supplement: Test meal E
    • Fortified extruded Rice was mixed with Commercial Rice (mixing Ratio: 1:100) The meal served with 30 g bean Sauce and 300 ml nanopure water. ** composition of extruded Rice: Ferric pyrophosphate, zinc sulfate, citric acid and trisodium Citrate.

Arms, Groups and Cohorts

  • Active Comparator: Reference meal 1
    • 50 g of Commercial Rice (Jasmin Rice) (dry weight) was cooked and 4 mg iron from Ferrous sulfate was added Prior to give to participants. Rice meal consumed with mixed vegetable Sauce.
  • Active Comparator: Reference 2
    • 50 g of Commercial Rice (Jasmin Rice) (dry weight) was cooked and 4 mg iron from Ferrous sulfate was added Prior to give to participants. Rice meal consumed with bean sauce.
  • Experimental: Test meal A
    • Commercial Rice (Jasmin Rice) was mixed with iron fortified extuded rice cofortified with zinc oxide and ethylenediaminetetraacetic acid (mixing ratio 100:1), Rice meal consumed with mixed vegetable Sauce.
  • Experimental: Test meal B
    • Commercial Rice (Jasmin Rice) was mixed with iron fortified extuded rice co-fortified with zinc sulfate and ethylenediaminetetraacetic acid (mixing ratio 100:1), Rice meal consumed with mixed vegetable Sauce.
  • Experimental: Test meal C
    • Commercial Rice (Jasmin Rice) was mixed with iron fortified extuded rice co-fortified with zinc sulfate, citric acid and trisodium citrate (mixing ratio 100:1), Rice meal consumed with mixed vegetable Sauce.
  • Experimental: Test meal D
    • Commercial Rice (Jasmin Rice) was mixed with iron fortified extuded rice co-fortified with zinc sulfafe and sodium pyrophosphate (mixing ratio 100:1), Rice meal consumed with mixed vegetable Sauce.
  • Experimental: Test meal E
    • Commercial Rice (Jasmin Rice) was mixed with iron fortified extuded rice co-fortified with zinc sulfate, citric acid and trisodium citrate (mixing ratio 100:1), Rice meal consumed with bean Sauce.

Clinical Trial Outcome Measures

Primary Measures

  • Change from baseline in the isotopic ratio of iron in blood at week 2
    • Time Frame: baseline, 2 weeks
    • The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes.
  • Change from week 2 in the isotopic ratio of iron in blood at week 4
    • Time Frame: 2 weeks, 4 weeks
    • The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes.
  • Change from week 4 in the isotopic ratio of iron in blood at week 6
    • Time Frame: 4 weeks, 6 weeks
    • The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes.
  • Change from week 6 in the isotopic ratio of iron in blood at week 8
    • Time Frame: 6 weeks, 8 weeks
    • The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes.
  • Change from week 8 in the isotopic ratio of iron in blood at week 10
    • Time Frame: 8 weeks, 10 weeks
    • The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes.

Secondary Measures

  • Haemoglobin
    • Time Frame: 2, 4,6,8 and 10 weeks
    • Haemoglobin of each timepoint
  • Plasma Ferritin
    • Time Frame: 2, 4, 6, 8 and 10 weeks
    • Plasma Ferritin of each timepoint
  • Inflammation Marker
    • Time Frame: 2, 4, 6, 8 and 10 weeks
    • Plasma Ferririn of each timepoint

Participating in This Clinical Trial

Inclusion Criteria

  • Female, 18 to 40 years old – Normal body Mass Index (18.5 – 25 kg/m2) – Body weight ≤ 65 kg – Signed informed consent Exclusion Criteria:

  • Pregnancy (assessed by self-declaration) – Lactating up to 6 weeks before study initiation – Anaemia (Hb < 12.0 g/dL) – Elevate CRP (>5.0 mg/L) – Any metabolic, gastrointestinal kidney or chronic disease such as diabetes, hepatitis, hypertension, cancer or cardiovascular diseases (according to the participants own statement) – Continuous/long-term use of medication during the whole study (except for contraceptives) – Consumption of mineral and vitamin supplements within 2 weeks prior to 1st meal administration – Blood transfusion, blood donation or significant blood loss (accident, surgery) over the past 4 months – Earlier participation in a study using Fe stable isotopes or participation in any clinical study within the last 30 days – Participant who cannot be expected to comply with study protocol (e.g. not available on certain study appointments) – Smokers (> 1 cigarette per week) – Difficulties with blood sampling – Male gender – Do not understand English

Gender Eligibility: Female

Minimum Age: 18 Years

Maximum Age: 40 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Swiss Federal Institute of Technology
  • Provider of Information About this Clinical Study
    • Sponsor

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.